BRAIN TUMOR, RECURRENT
Clinical trials for BRAIN TUMOR, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, RECURRENT trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Gadolinium-Free MRI dye shows promise for brain lesion detection
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001 in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions without using gadolinium, a metal that can build up in the bo…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated May 26, 2026 04:35 UTC
-
New MRI dye shows promise for spotting brain tumors
Diagnosis CompletedThis study tested a new contrast agent called Elucirem (gadopiclenol) for MRI scans of brain gliomas. It involved 138 adults with new or returning brain tumors. The goal was to see if Elucirem produced clearer images than the standard contrast agent, Dotarem, when measuring blood…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated May 26, 2026 04:28 UTC